Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Regencell Bioscience (RGC)
NASDAQ:RGC
Holding RGC?
Track your performance easily
RGC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.03 - $32.44
Previous CloseN/A
Volume4.26K
Average Volume (3M)9.44K
Market Cap
$62.44M
Enterprise ValueN/A
Total Cash (Recent Filing)$386.98K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-2.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding13,012,866
10 Day Avg. Volume3,384
30 Day Avg. Volume9,441
Standard Deviation0.57
R-Squared0.00214
Alpha0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Regencell Bioscience News
PremiumCompany Announcements
Regencell Bioscience Extends Lock-Up Period for Stock Options
Ownership Overview
―
Insiders
0.05%
Mutual Funds
― Other Institutional Investors
99.95% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RGC FAQ
What was Regencell Bioscience’s price range in the past 12 months?
Regencell Bioscience lowest stock price was $3.03 and its highest was $32.44 in the past 12 months.
What is Regencell Bioscience’s market cap?
Regencell Bioscience’s market cap is $62.44M.
When is Regencell Bioscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regencell Bioscience’s earnings last quarter?
Currently, no data Available
Is Regencell Bioscience overvalued?
According to Wall Street analysts Regencell Bioscience’s price is currently Overvalued.
Does Regencell Bioscience pay dividends?
Regencell Bioscience does not currently pay dividends.
What is Regencell Bioscience’s EPS estimate?
Regencell Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regencell Bioscience have?
Regencell Bioscience has 13,012,866 shares outstanding.
What happened to Regencell Bioscience’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Regencell Bioscience?
Currently, no hedge funds are holding shares in RGC
---
Regencell Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.20%
12-Months-Change
Fundamentals
Return on Equity
-42.49%
Trailing 12-Months
Asset Growth
-33.15%
Trailing 12-Months
Company Description
Regencell Bioscience
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
---
Technical Analysis
---